Journal issue - WANFANG MED ONLINE

Contact US | Chinese

You Position: Home > Journal issue

Chinese Journal of Nuclear Medicine

Issue 2, 2019

Items 1-5 of 15

«Preious | of 3 | Next»

1

18F-FDG PET/CT in primitive neuroectodermal tumor/Ewing sarcoma: a case report

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 39, Issue 2,2019, Pages 104-105, doi:10.3760/cma.j.issn.2095-2848.2019.02.010

2

Role of 68Ga/177Lu-PSMA in theranostic of prostate cancer

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 39, Issue 2,2019, Pages 65-66, doi:10.3760/cma.j.issn.2095-2848.2019.02.001

3

Safety and efficacy of 177Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 39, Issue 2,2019, Pages 81-85, doi:10.3760/cma.j.issn.2095-2848.2019.02.005

4

Efficacy analysis of CT-guided 125I seeds implantation combined with chemotherapy in the treatment of unresectable non-small cell lung cancer

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 39, Issue 2,2019, Pages 96-99, doi:10.3760/cma.j.issn.2095-2848.2019.02.008

5

Influence of proteasome activator γ on iodine uptake capability of anaplastic thyroid carcinoma

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 39, Issue 2,2019, Pages 100-103, doi:10.3760/cma.j.issn.2095-2848.2019.02.009

Items 1-5 of 15

«Preious | of 3 | Next»

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn